REASON: A Registry for the Epidemiologic and Scientific evaluation of EGFR mutation status in newly diagnosed NSCLC patients stage IIIB/IV in Germany. 1. Juni 2011 Schuette, W., Eberhardt, W., Graf von der Schulenburg, J.-M., Dietel, M., Schirmacher, P., Gutendorf, B., Thomas, M., 2011. Amsterdam; 2011. LICC: L-BLP25 in patients with colorectal carcinoma after curative resection of hepatic metastases – A randomized, double-blind, placebo-controlled, multicenter, multinational, phase II trial. Schimanski, C.C., Galle, P., Lang, H., Schoen, M., Moehler, M., 2011. J Clin Oncol 29 (suppl)(Abstract TPS166). Abstract… Weiterlesen Treatment of cancer- and chemotherapy-associated anemia with ferric carboxymaltose in clinical practice. Steinmetz, T., Tschechne, B., Harlin, O., Klement, B., Franzem, M., Wamhoff, J., Tech, H., Rohrberg, R., Marschner, N., 2011. Onkologie 34 (suppl 6)(V1012), 304. doi:10.1159/000333303… Weiterlesen